 | • レポートコード：QFJ1-5749 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、遺伝子治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（神経筋疾患、遺伝病、その他）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・遺伝子治療薬の市場動向 ・企業の競争状況、市場シェア ・遺伝子治療薬の種類別市場規模と予測2016-2027（神経筋疾患、遺伝病、その他） ・遺伝子治療薬の用途別市場規模と予測2016-2027（病院、薬局） ・遺伝子治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝子治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝子治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝子治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝子治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（F. Hoffmann-La Roche AG、Novartis International AG、Gilead Sciences, Inc.、Ultragenyx Pharmaceutical，Inc.、Applied Genetic Technologies Corp、Audentes Therapeutics、BioMarin Pharmaceutical、Bluebird Bio、Nightstar Therapeutics、Sangamo Therapeutics、Spark Therapeutics、uniQure、VBL Therapeutics、Voyager Therapeutics） ・結論 |
Market Analysis and Insights: Global Gene Therapy Drugs Market
The global Gene Therapy Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy Drugs market.
Global Gene Therapy Drugs Scope and Market Size
Gene Therapy Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Neuromuscular Disease
Genetic Disease
Other
Segment by Application
Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences, Inc.
Ultragenyx Pharmaceutical，Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Neuromuscular Disease
1.2.3 Genetic Disease
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Therapy Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Drugs Market Perspective (2016-2027)
2.2 Gene Therapy Drugs Growth Trends by Regions
2.2.1 Gene Therapy Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy Drugs Industry Dynamic
2.3.1 Gene Therapy Drugs Market Trends
2.3.2 Gene Therapy Drugs Market Drivers
2.3.3 Gene Therapy Drugs Market Challenges
2.3.4 Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Drugs Players by Revenue
3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Drugs Revenue
3.4 Global Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2020
3.5 Gene Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Gene Therapy Drugs Product Solution and Service
3.7 Date of Enter into Gene Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Drugs Breakdown Data by Type
4.1 Global Gene Therapy Drugs Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2022-2027)
5 Gene Therapy Drugs Breakdown Data by Application
5.1 Global Gene Therapy Drugs Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gene Therapy Drugs Market Size (2016-2027)
6.2 North America Gene Therapy Drugs Market Size by Type
6.2.1 North America Gene Therapy Drugs Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy Drugs Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy Drugs Market Size by Type (2016-2027)
6.3 North America Gene Therapy Drugs Market Size by Application
6.3.1 North America Gene Therapy Drugs Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy Drugs Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy Drugs Market Size by Application (2016-2027)
6.4 North America Gene Therapy Drugs Market Size by Country
6.4.1 North America Gene Therapy Drugs Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gene Therapy Drugs Market Size (2016-2027)
7.2 Europe Gene Therapy Drugs Market Size by Type
7.2.1 Europe Gene Therapy Drugs Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy Drugs Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy Drugs Market Size by Type (2016-2027)
7.3 Europe Gene Therapy Drugs Market Size by Application
7.3.1 Europe Gene Therapy Drugs Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy Drugs Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy Drugs Market Size by Application (2016-2027)
7.4 Europe Gene Therapy Drugs Market Size by Country
7.4.1 Europe Gene Therapy Drugs Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Drugs Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy Drugs Market Size by Type
8.2.1 Asia-Pacific Gene Therapy Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy Drugs Market Size by Application
8.3.1 Asia-Pacific Gene Therapy Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region
8.4.1 Asia-Pacific Gene Therapy Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy Drugs Market Size (2016-2027)
9.2 Latin America Gene Therapy Drugs Market Size by Type
9.2.1 Latin America Gene Therapy Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy Drugs Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy Drugs Market Size by Application
9.3.1 Latin America Gene Therapy Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy Drugs Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy Drugs Market Size by Country
9.4.1 Latin America Gene Therapy Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Drugs Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy Drugs Market Size by Type
10.2.1 Middle East & Africa Gene Therapy Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy Drugs Market Size by Application
10.3.1 Middle East & Africa Gene Therapy Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country
10.4.1 Middle East & Africa Gene Therapy Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Details
11.1.2 F. Hoffmann-La Roche AG Business Overview
11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2016-2021)
11.1.5 F. Hoffmann-La Roche AG Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Gene Therapy Drugs Introduction
11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2016-2021)
11.2.5 Novartis International AG Recent Development
11.3 Gilead Sciences, Inc.
11.3.1 Gilead Sciences, Inc. Company Details
11.3.2 Gilead Sciences, Inc. Business Overview
11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2016-2021)
11.3.5 Gilead Sciences, Inc. Recent Development
11.4 Ultragenyx Pharmaceutical，Inc.
11.4.1 Ultragenyx Pharmaceutical，Inc. Company Details
11.4.2 Ultragenyx Pharmaceutical，Inc. Business Overview
11.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Introduction
11.4.4 Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2016-2021)
11.4.5 Ultragenyx Pharmaceutical，Inc. Recent Development
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Details
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2016-2021)
11.5.5 Applied Genetic Technologies Corp Recent Development
11.6 Audentes Therapeutics
11.6.1 Audentes Therapeutics Company Details
11.6.2 Audentes Therapeutics Business Overview
11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021)
11.6.5 Audentes Therapeutics Recent Development
11.7 BioMarin Pharmaceutical
11.7.1 BioMarin Pharmaceutical Company Details
11.7.2 BioMarin Pharmaceutical Business Overview
11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2016-2021)
11.7.5 BioMarin Pharmaceutical Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2016-2021)
11.8.5 Bluebird Bio Recent Development
11.9 Nightstar Therapeutics
11.9.1 Nightstar Therapeutics Company Details
11.9.2 Nightstar Therapeutics Business Overview
11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021)
11.9.5 Nightstar Therapeutics Recent Development
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Details
11.10.2 Sangamo Therapeutics Business Overview
11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021)
11.10.5 Sangamo Therapeutics Recent Development
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Details
11.11.2 Spark Therapeutics Business Overview
11.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
11.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021)
11.11.5 Spark Therapeutics Recent Development
11.12 uniQure
11.12.1 uniQure Company Details
11.12.2 uniQure Business Overview
11.12.3 uniQure Gene Therapy Drugs Introduction
11.12.4 uniQure Revenue in Gene Therapy Drugs Business (2016-2021)
11.12.5 uniQure Recent Development
11.13 VBL Therapeutics
11.13.1 VBL Therapeutics Company Details
11.13.2 VBL Therapeutics Business Overview
11.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
11.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021)
11.13.5 VBL Therapeutics Recent Development
11.14 Voyager Therapeutics
11.14.1 Voyager Therapeutics Company Details
11.14.2 Voyager Therapeutics Business Overview
11.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
11.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021)
11.14.5 Voyager Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Gene Therapy Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neuromuscular Disease
Table 3. Key Players of Genetic Disease
Table 4. Key Players of Other
Table 5. Global Gene Therapy Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gene Therapy Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gene Therapy Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gene Therapy Drugs Market Share by Regions (2016-2021)
Table 9. Global Gene Therapy Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gene Therapy Drugs Market Share by Regions (2022-2027)
Table 11. Gene Therapy Drugs Market Trends
Table 12. Gene Therapy Drugs Market Drivers
Table 13. Gene Therapy Drugs Market Challenges
Table 14. Gene Therapy Drugs Market Restraints
Table 15. Global Gene Therapy Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gene Therapy Drugs Market Share by Players (2016-2021)
Table 17. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy Drugs as of 2020)
Table 18. Ranking of Global Top Gene Therapy Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gene Therapy Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Therapy Drugs Product Solution and Service
Table 22. Date of Enter into Gene Therapy Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gene Therapy Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Gene Therapy Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gene Therapy Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gene Therapy Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gene Therapy Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Gene Therapy Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gene Therapy Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gene Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gene Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gene Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gene Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gene Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gene Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gene Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gene Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gene Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gene Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gene Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gene Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gene Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gene Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Therapy Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gene Therapy Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gene Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gene Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gene Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gene Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gene Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gene Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gene Therapy Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gene Therapy Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Therapy Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Therapy Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Therapy Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gene Therapy Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. F. Hoffmann-La Roche AG Company Details
Table 63. F. Hoffmann-La Roche AG Business Overview
Table 64. F. Hoffmann-La Roche AG Gene Therapy Drugs Product
Table 65. F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 66. F. Hoffmann-La Roche AG Recent Development
Table 67. Novartis International AG Company Details
Table 68. Novartis International AG Business Overview
Table 69. Novartis International AG Gene Therapy Drugs Product
Table 70. Novartis International AG Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 71. Novartis International AG Recent Development
Table 72. Gilead Sciences, Inc. Company Details
Table 73. Gilead Sciences, Inc. Business Overview
Table 74. Gilead Sciences, Inc. Gene Therapy Drugs Product
Table 75. Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 76. Gilead Sciences, Inc. Recent Development
Table 77. Ultragenyx Pharmaceutical，Inc. Company Details
Table 78. Ultragenyx Pharmaceutical，Inc. Business Overview
Table 79. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product
Table 80. Ultragenyx Pharmaceutical，Inc. Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 81. Ultragenyx Pharmaceutical，Inc. Recent Development
Table 82. Applied Genetic Technologies Corp Company Details
Table 83. Applied Genetic Technologies Corp Business Overview
Table 84. Applied Genetic Technologies Corp Gene Therapy Drugs Product
Table 85. Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 86. Applied Genetic Technologies Corp Recent Development
Table 87. Audentes Therapeutics Company Details
Table 88. Audentes Therapeutics Business Overview
Table 89. Audentes Therapeutics Gene Therapy Drugs Product
Table 90. Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 91. Audentes Therapeutics Recent Development
Table 92. BioMarin Pharmaceutical Company Details
Table 93. BioMarin Pharmaceutical Business Overview
Table 94. BioMarin Pharmaceutical Gene Therapy Drugs Product
Table 95. BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 96. BioMarin Pharmaceutical Recent Development
Table 97. Bluebird Bio Company Details
Table 98. Bluebird Bio Business Overview
Table 99. Bluebird Bio Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 100. Bluebird Bio Recent Development
Table 101. Nightstar Therapeutics Company Details
Table 102. Nightstar Therapeutics Business Overview
Table 103. Nightstar Therapeutics Gene Therapy Drugs Product
Table 104. Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 105. Nightstar Therapeutics Recent Development
Table 106. Sangamo Therapeutics Company Details
Table 107. Sangamo Therapeutics Business Overview
Table 108. Sangamo Therapeutics Gene Therapy Drugs Product
Table 109. Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 110. Sangamo Therapeutics Recent Development
Table 111. Spark Therapeutics Company Details
Table 112. Spark Therapeutics Business Overview
Table 113. Spark Therapeutics Gene Therapy Drugs Product
Table 114. Spark Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 115. Spark Therapeutics Recent Development
Table 116. uniQure Company Details
Table 117. uniQure Business Overview
Table 118. uniQure Gene Therapy Drugs Product
Table 119. uniQure Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 120. uniQure Recent Development
Table 121. VBL Therapeutics Company Details
Table 122. VBL Therapeutics Business Overview
Table 123. VBL Therapeutics Gene Therapy Drugs Product
Table 124. VBL Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 125. VBL Therapeutics Recent Development
Table 126. Voyager Therapeutics Company Details
Table 127. Voyager Therapeutics Business Overview
Table 128. Voyager Therapeutics Gene Therapy Drugs Product
Table 129. Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2016-2021) & (US$ Million)
Table 130. Voyager Therapeutics Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy Drugs Market Share by Type: 2020 VS 2027
Figure 2. Neuromuscular Disease Features
Figure 3. Genetic Disease Features
Figure 4. Other Features
Figure 5. Global Gene Therapy Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Pharmacy Case Studies
Figure 8. Gene Therapy Drugs Report Years Considered
Figure 9. Global Gene Therapy Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Gene Therapy Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gene Therapy Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Gene Therapy Drugs Market Share by Regions (2022-2027)
Figure 13. Global Gene Therapy Drugs Market Share by Players in 2020
Figure 14. Global Top Gene Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy Drugs Revenue in 2020
Figure 16. Global Gene Therapy Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Gene Therapy Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Gene Therapy Drugs Market Share by Type (2016-2027)
Figure 20. North America Gene Therapy Drugs Market Share by Application (2016-2027)
Figure 21. North America Gene Therapy Drugs Market Share by Country (2016-2027)
Figure 22. United States Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gene Therapy Drugs Market Share by Type (2016-2027)
Figure 26. Europe Gene Therapy Drugs Market Share by Application (2016-2027)
Figure 27. Europe Gene Therapy Drugs Market Share by Country (2016-2027)
Figure 28. Germany Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gene Therapy Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Gene Therapy Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Gene Therapy Drugs Market Share by Region (2016-2027)
Figure 38. China Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gene Therapy Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Gene Therapy Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Gene Therapy Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gene Therapy Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Gene Therapy Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Gene Therapy Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Gene Therapy Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. F. Hoffmann-La Roche AG Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 58. Novartis International AG Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 59. Gilead Sciences, Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 60. Ultragenyx Pharmaceutical，Inc. Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 61. Applied Genetic Technologies Corp Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 62. Audentes Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 63. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 64. Bluebird Bio Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 65. Nightstar Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 66. Sangamo Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 67. Spark Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 68. uniQure Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 69. VBL Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 70. Voyager Therapeutics Revenue Growth Rate in Gene Therapy Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年） In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome. Gene therapy has the potential to cure …- 世界の遺伝子治療医学市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gene Therapy Medicine Market The global Gene Therapy Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gene Therapy Medicinal Products (GTMP) Market The global Gene Therapy Medicinal Products (GTMP) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界の遺伝子検出用個別化癌治療市場規模・現状・予測（2021年-2027年） A method to provide patients with individualized treatment of cancer tumors Market Analysis and Insights: Global Gene Detection for Individualized Cancer Therapy Market The global Gene Detection for Individualized Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX m…
- 遺伝性疾患用遺伝子治療のグローバル市場：規模・現状・予測2019-2025 In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.Gene therapy has the potential to cure i…